Post A Reply
my profile
login
|
register
|
search
|
faq
|
forum home
»
Allstocks.com's Bulletin Board
»
Micro Penny Stocks, Penny Stocks $0.10 & Under
»
XKEM
» Post A Reply
Post A Reply
Login Name:
Password:
Message Icon:
Message:
HTML is not enabled.
UBB Code™ is enabled.
[QUOTE]Originally posted by Ztiger: [QB] This was filled on June 20 2006 -----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster*www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, C8uB19UWqXIeuR8L31dE2Vxn52yGpQhzqz2+nZ3BX/+FHC7ZIl4o4szOtTIZ+Eo1 iVRHiGAV30Nl4BNUsZ3cvQ== <SEC-DOCUMENT>0001144204-06-025489.txt : 20060620 <SEC-HEADER>0001144204-06-025489.hdr.sgml : 20060620 <ACCEPTANCE-DATETIME>20060620172842 ACCESSION NUMBER: 0001144204-06-025489 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20060615 ITEM INFORMATION: Entry into a Material Definitive Agreement ITEM INFORMATION: Unregistered Sales of Equity Securities ITEM INFORMATION: Other Events FILED AS OF DATE: 20060620 DATE AS OF CHANGE: 20060620 FILER: COMPANY DATA: COMPANY CONFORMED NAME: XECHEM INTERNATIONAL INC CENTRAL INDEX KEY: 0000919611 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 323284803 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 000-23788 FILM NUMBER: 06915881 BUSINESS ADDRESS: STREET 1: 100 JERSEY AVE E STREET 2: BLDG B STE 310 CITY: NEW BRUNSWICK STATE: NJ ZIP: 08901 BUSINESS PHONE: 9082473300 MAIL ADDRESS: STREET 1: 100 JERSEY AVE STREET 2: STE B310 CITY: NEW BRUNSWICK STATE: NJ ZIP: 08901 </SEC-HEADER> <DOCUMENT> <TYPE>8-K <SEQUENCE>1 <FILENAME>v045664_8k.txt <TEXT> ================================================================================ SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities and Exchange Act of 1934 Date of Report: June 15, 2006 (Date of earliest event reported) XECHEM INTERNATIONAL, INC. (Exact name of registrant as specified in the charter) Delaware 0-23788 22-3284403 (State or other jurisdiction (Commission File No.) (IRS Employer of incorporation) Identification No.) New Brunswick Technology Center 100 Jersey Avenue, Building B, Suite 310 New Brunswick, New Jersey 08901-3279 (Address of Principal Executive Offices) (732) 247-3300 Registrant's telephone number including area code) NOT APPLICABLE (Former name or former address, if changed since last report) --------------- Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below): |_| Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) |_| Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) |_| Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) |_| Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) ================================================================================ <PAGE> ITEM 1.01 ENTRY INTO A MATERIAL DEFINITIVE AGREEMENT. Please see the disclosure under Item 3.02 herein. ITEM 3.02 UNREGISTERED SALES OF EQUITY SECURITIES. On June 15, 2006, Xechem International, Inc. reached final agreement with Marjorie Chassman ("Chassman") regarding a bridge loan financing, whereby Chassman agrees to loan $1,025,000 to Xechem, in two tranches, one in the amount of $500,000 and the other in the amount of $525,000. The first tranche of $500,000 was infused on Friday, June 9, 2006. The second tranche of $525,000 is due by Friday, June 23, 2006. The note has been negotiated to convert into shares of our common stock at $0.015 per share (approximately 66,666,667 shares, excluding interest). The note bears interest at 8% and is due May 31, 2008. As additional consideration for infusion of the capital, Xechem will issue Chassman 66,666,667 warrants, exercisable at $0.02 per share for a period of 5 years. In addition, Chassman has agreed to extend the due date on all existing notes held by the Company to May 31, 2008. The loan has not been documented at this time. Upon documentation, it will be filed as an exhibit. Over the period from June 2, 2006 through June 5, 2006, Chassman infused $200,000 into Xechem. On June 15, 2006, the parties reached final agreement as to the terms: the note will be issued to Chassman in the amount of $200,000, it will bear interest at 8% and is due May 31, 2008. The note is convertible into shares of our common stock at $0.01 per share (20,000,000 shares, excluding interest). The loan has not been documented at this time. Upon documentation, it will be filed as an exhibit. Over the period from February 22, 2006 through May 10, 2006, Chassman infused $780,000 into Xechem, as reflected in Xechem's annual and quarterly reports. On June 15, 2006, the parties reached final agreement as to the terms: the note will be issued to Chassman in the amount of $780,000, it will bear interest at 8% and is due May 31, 2008. The note is convertible into shares of our common stock at $0.005 per share (approximately 156,000,000 shares, excluding interest). The loan has not been documented at this time. Upon documentation, it will be filed as an exhibit. The Company relied upon the exemption from registration available under Section 4(2) of the Securities Act of 1933, as amended. The Bridge Loan Financing participant is an accredited investor, small in number, and has had access to information about Xechem. ITEM 8.01 OTHER EVENTS. During the period from April 6, 2006 through June 8, 2006, Xechem International, Inc., converted Xechem debt (in the form of principal and interest) in the aggregate amount of approximately $563,000 ($526,000 of which was principal and $37,000 of which was interest) into approximately 144,511,809 shares of Xechem's common stock (exercised at conversion rates between $0.0025-$0.0075 per share), representing approximately 12% of Xechem's currently issued and outstanding stock. <PAGE> ITEM 9.01 EXHIBITS. (C) EXHIBITS. None. SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. Dated: June 20, 2006 XECHEM INTERNATIONAL, INC. By: /s/ Ramesh C. Pandey ------------------------------------ Ramesh C. Pandey, Ph.D Chairman & CEO </TEXT> </DOCUMENT> </SEC-DOCUMENT> -----END PRIVACY-ENHANCED MESSAGE----- [/QB][/QUOTE]
Instant Graemlins
Instant UBB Code™
What is UBB Code™?
Options
Disable Graemlins in this post.
*** Click here to review this topic. ***
Contact Us
|
Allstocks.com Message Board Home
© 1997 - 2021 Allstocks.com. All rights reserved.
Powered by
Infopop Corporation
UBB.classic™ 6.7.2